Juvenile idiopathic arthritis in two tertiary centres in the Western Cape, South Africa by Weakley, Kate
The copyright of this thesis vests in the author. No 
quotation from it or information derived from it is to be 
published without full acknowledgement of the source. 
The thesis is to be used for private study or non-
commercial research purposes only. 
Published by the University of Cape Town (UCT) in terms 

























Juvenile Idiopathic Arthritis in 
two Tertiary Centres in the 
Western Cape, South Africa
Kate Weakley
WKLKAT001
Submitted to the University of Cape Town in partial requirement 
for the degree of MMed(paediatrics)
Faculty of Health Science 
University of Cape Town 
















Table of Contents 
Declaration ............................................................................................................................ iii 
1. Protocol .......................................................................................................................... 1 
(Submitted to School of Child and Adolescent Health UCT before commencement of the 
study) ..................................................................................................................................... 1 
1.1. Introduction ............................................................................................................ 1 
1.2. Objectives ............................................................................................................... 2 
1.3. Methods .................................................................................................................. 2 
1.3.4 Investigators ........................................................................................................... 4 
Investigators would include doctors and nurses in the rheumatology clinic at Groote 
Schuur Hospital. ................................................................................................................. 4
1.4 References .............................................................................................................. 6 
2 Protocol Amendment 1 .................................................................................................. 8 
3 Literature Review ........................................................................................................... 9 
3.1 Objectives of literature review ............................................................................... 9
3.2 Literature Search Strategy ...................................................................................... 9
3.3 Literature .............................................................................................................. 11
3.4 Studies describing JIA ........................................................................................... 12
3.6 Conclusion............................................................................................................. 22
3.7References .................................................................................................................. 24
4 Journal article............................................................................................................... 27
4.1 Abstract................................................................................................................. 27
4.2 Introduction .......................................................................................................... 28
4.3 Methods................................................................................................................ 31
4.4 Procedures ............................................................................................................ 31




4.9 References ............................................................................................................ 48 
5 Appendices ................................................................................................................... 52 
5.1 ILAR Classification ................................................................................................. 52 
5.2 CHAQ English ........................................................................................................ 55 
5.3 CHAQ Xhosa .......................................................................................................... 57 
5.4 CHAQ Zulu ............................................................................................................. 59 
5.5 CHAQ Afrikaans ..................................................................................................... 61 
5.6 Data collection sheet ............................................................................................ 63 
5.8 Consent Form: Participation in study on arthritis in the Western Cape. ............. 65 
5.9 Ethics Approval, University of Cape Town ............................................................ 66 















I, ………………………………, hereby declare that the work on which this dissertation/thesis is 
based is my original work (except where acknowledgements indicate otherwise) and that 
neither the whole work nor any part of it has been, is being, or is to be submitted for 
another degree in this or any other university. 
I empower the university to reproduce for the purpose of research either the whole or 















Juvenile Idiopathic Arthritis in two Tertiary Centres in the Western Cape, South Africa 
1 
1. Protocol
(Submitted to School of Child and Adolescent Health UCT before commencement of 
the study) 
1.1. Introduction 
Juvenile idiopathic arthritis (JIA) is defined as arthritis of unknown aetiology that begins 
before the 16th birthday and persists for at least 6 weeks, other conditions being
excluded. It has become a well defined and classified disease with the revised
International League of Associations for Rheumatology (ILAR) classification in Edmonton
in 2001. 1
As JIA is a disease with serious functional implications, a descriptive study would not be 
complete without reviewing both the functional and clinical parameters of the disease. 
Juvenile idiopathic arthritis has been poorly researched the South African context. A
descriptive study was done in 1984 about JIA specifically in South African children of
black and indian descent2.  It was a retrospective study of 60 patients from the R K Khan
Hospital complex in Durban, South Africa, using the old WHO/EULAR classification. There 
have been numerous descriptive studies done in countries throughout the world, 
including westernised countries such as the USA3 and Britain4 as well as studies in
developing countries such as Turkey5, Morocco6 and India7. These will all be vital for
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From a functional perspective, a recent study in 2009 looked at describing JIA in
Moroccan patients6. The study described health related quality of life (HRQOL), functional 
disability, using the child health assessment questionnaire (CHAQ) as well as types of JIA, 
clinical determinants and laboratory parameters. A recent multinational study by the
Paediatric Rheumatology International Trials Organisation (PRINTO) compared HRQOL 
and functional disability (using CHAQ) from 3 geographic areas, including 16 Western
European Countries, 10 Eastern European countries and 4 Latin American countries8.
From, the above, it is clear that there has been a lot of recent work into describing JIA in
both developed and developing countries in terms of clinical disease, HRQOL and
functional disability. There has been very little African data, however, on this subject. 
1.2. Objectives 
To describe the functional disability and clinical disease characteristics in a sample of
children diagnosed with JIA in Cape Town, South Africa. 
1.3. Methods
1.3.1. Study Design 
This is a prospective cross sectional study. 
1.3.2. Subjects 
Subjects will be from Groote Schuur Hospital Rheumatology clinic (Please see amendment 
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from the Cape Town area. This clinic serves the population of the Western Cape region of 
South Africa and also acts as a tertiary referral area to other large regions of South Africa 
such as the Northern and Eastern Cape. It is thus a large area of South Africa representing 
a culturally diverse population. 
Patients will be randomly sampled from the clinic attendees.Patients should be younger 
than 16 when diagnosed with Juvenile idiopathic arthritis as well as classified by a 
paediatric rheumatologist into an ILAR 2001 subtype.(Appendix 1) 
1.3.3. Measurement 
Functional disability is assessed using the CHAQ9; 10 which has been used in both the
Moroccan6 study as well as the PRINTO8 series and is thus a well validated questionnaire
in both developing and developed worlds. It would be useful in comparing data from 
these studies.  
The CHAQ has been translated into Afrikaans, English, Zulu and Xhosa, some of the 4 main
languages of the area. The mother or child (when capable) would be asked to fill out the
CHAQ with the help of the doctor or nurse attending to them at the clinic. The CHAQ 
measures the child’s ability to perform functions in 8 areas (dressing and grooming,
arising, eating, walking, hygiene, reach, grip and activity) for a total number of 30.Each
question is scored from 0 to 3 (0 = no difficulty, 1 = some difficulty, 2 = much difficulty, 3 = 
unable to do so). The question with the highest score determines the score for that
functional area. If aids or devices are used or help is needed to complete tasks in a certain
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for each of the eight functional areas are averaged to calculate the CHAQ disability index 
(DI), which ranges from 0 to 3 (0 = best; 3 = worst). The parent's version of the CHAQ
incorporates also a doubly-anchored horizontal 10 cm visual analogue scale (VAS) for the 
assessment of the child's overall well-being(parent general evaluation-PGE-with anchors 
of ‘0 = very well’ and ‘10 = very poor’) and a doubly-anchored horizontal 10 cm VAS for 
the assessment of the intensity of the child's pain (with anchors of ‘0 = no pain’ and ‘10 = 
very severe pain’). 5 
On a separate excel spreadsheet (appendix 5) for each patient there is a record of study
number, age (0-16), sex (M/F), primary caregiver (mother/father/grandparent/aunt etc), 
age at diagnosis, area of residence (suburb/township) and level of schooling (Grade 1-12). 
Importantly, there would also be a record of whether the child had ever had TB or HIV. 
There would be a diagram where one could record involved joints including active 
(swollen or limited and tender) and limited joints (joints with a limited range of 
motion).(Appendix 6). There would also be a place for the recording of laboratory results 
(if available), namely anti nuclear antibodies (ANA), rheumatoid factor (RF), human
leukocyte antigen B27 (HLA B27), haemoglobin (Hb), platelets (Plts) erythrocyte
sedimentation rate (ESR), C-reactive protein (CRP), the liver transaminases- ALT and AST, 
and creatinine. 
1.3.4 Investigators 
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1.3.5 Ethics 
Each patient will be allocated a study number and therefore will have their confidentiality 
protected. No additional tests or interventions will be performed on patients for the 
purpose of the study. Informed consent will be obtained by parents, or where capable, 
patients. 
1.3.6 Reporting and implementation 
The finalised documentation and data will be presented to School of Child and Adolescent 
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2 Protocol Amendment 1 
(Submitted to School of Child and Adolescent Health) 
Please be advised that this protocol will also be submitted to Stellenbosch University 
Ethics Committee to seek approval for the collection of data from the Tygerberg Hospital 
Paediatric Rheumatology Clinic which is attended by the study supervisor Dr Chris Scott. 
Should the Stellenbosch Ethics Committee approve, the data collected will be used with 
the data from Groote Schuur Hospital for the purposes of the study. The initial protocol, 
approved by the school of child and adolescent health, only specified that data from 
Groote Schuur would be collected. 
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3 Literature Review 
3.1 Objectives of literature review 
The objective of this study is to describe the functional disability and clinical disease 
characteristics of Juvenile Idiopathic Arthritis (JIA) in a sample of children diagnosed with 
JIA in Cape Town, South Africa. 
 The main objectives of this literature review is to 
Identify studies that would be useful in comparing South African data to other
cohorts
To assist in finding validated variables and scores which have been standardly
used to assess the type, functional outcome and severity of JIA. 
JIA is a poorly described disease in an African context, so recent work from other 
developing countries is valuable in assessing South African data. Standardised, validated
variables are needed to ensure quality data collection that can be meaningfully compared
to international data. 
3.2  Literature Search Strategy 
An internet search, using pubmed was undertaken. Phrases searched were Juvenile 
Idiopathic Arthritis AND functional disability OR disease characteristics. This search 
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Inclusion criteria for previous patient based studies were 
Studies with at least 30 subjects 
Studies that, despite their objectives described 








Other relevant information such as age at onset, joints involved, pain and 
general wellbeing. 
To summarise, the most basic study that was accepted would need to have a group of 
type-classified patients with JIA. Classification of JIA is difficult as there is only recently a 
well accepted international classification, so both old ACR (American College of 
Rheumatology)1 and EULAR (European League Against Rheumatism)1  were excluded and 
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was accepted. The only exception was a South African study done in 1984 which uses the 
EULAR classification but was the only South African data found, so it was included.  
There was also no time limit set on publication of studies, but obviously more recent and 
larger studies were favoured when the most relevant literature was selected. 
3.3 Literature 
3.3.1 Definition 
The first necessary step is a definition of JIA. There has been a history of difficulty on this
subject. In 1977, two sets of classifications were formulated, the European criteria 
(European League against Rheumatism, EULAR)1 for Juvenile Chronic Arthritis, and the 
North American Criteria (American college of Rheumatology, ACR) for Juvenile Rheumatic
Arthritis2. Both systems used age criteria as 16 years and below, the EULAR included
spondyloarthropathy and required the disease to be present for 12 weeks, the ACR did
not include spondyloarthropathy and required the disease to be present for 6 weeks 
only.3 
In many of the early descriptions of JIA, therefore the two different names and criteria are 
used. One classification totally excluded the subgroup of patients with 
spondyloarthropathy (now known as enthesitis related arthritis). 
In 1995, the first international classification was formulated with an amendment in 
19974;5. The most recent classification is the International League of Rheumatology (ILAR) 
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aetiology that begins before the 16th birthday and persists for at least 6 weeks, other 
conditions being excluded. 
It classifies JIA as   
Systemic Arthritis 
Oligoarthritis 
Polyarthritis-rheumatoid factor negative 
Polyarthritis- rheumatoid factor positive 
Psoriatic arthritis 
Enthesitis Related arthritis 
Undifferentiated arthritis 
This classification has been widely used, and found to be easy to use and transparent in 
an evaluation published in 20057. 
3.4 Studies describing JIA 
Below are summaries of the most relevant articles 
3.4.1 Morocco 8 
This is a cross sectional study that recruited 80 patients with JIA according to ILAR criteria, 
over 18 months. The aim was to assess health related quality of life and its’ determinants 
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visual analogue scales(VAS) for pain and  parent general evaluation (PGE) and lab 
parameters were obtained. Each  patient also had a childhood health assessment 
questionnaire(CHAQ) to assess functional disability as well as a juvenile arthritis quality of 
life questionnaire (JAQQ) . There were only a few enthesitis related arthritis (ERA) and 
psoriatic arthritis patients, so the categories were excluded from further consideration.  
 All patients were classified according to ILAR but in the results there is no differentiation 
between rheumatoid factor(RF) positive or negative polyarthritis patients, they are just 
counted together as polyarthritis.  
It was found that disability was higher in adolescents and in patients with polyarticular 
and systemic subtypes as opposed to oligoarticular. Health related quality of life was 
significantly associated with CHAQ score, JIA  subtype (worse in polyarticular and systemic 
subtypes), female sex and  number of joints  with limitation. 
This is a very useful study for the purpose of this literature review. Most importantly it is a 
study from a 3rd world context in an African country. Obviously, it has a different 
objective, but a lot of the same data has been collected. The subtypes, as well as age of 
onset, ESR and CHAQ can all be used to describe JIA as well as functional disability. There 
is no mention of whether variables are normally distributed, but the numerical variables 
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3.4.2 Childhood Arthritis Prospective Study (CAPS)-UK 9 
This study is a prospective longitudinal inception cohort study which aims to provide 
information on the long term outcome of children with JIA following routine care in the 
UK.  In 2010, an analysis was published with the aim to describe the outcomes of children 
1 year after 1st presentation to paediatric rheumatology and to identify factors that 
predicted moderate to severe disability at 1 year. 
 The CAPS study has been recruiting since 2001. Eligibility includes children aged 16 or less 
presenting to one of five paediatric rheumatology referral centres with a new diagnosis of 
inflammatory arthritis.  Demographic data and medians of joint count, CHAQ, PGE, VAS 
and ESR are collected at first presentation and then again at 6 and 12 months.  
This study is the largest prospective report of early outcomes in a cohort of children with 
JIA. It was concluded that after one year of presentation the majority of children will have 
significant improvement in pain, joint inflammation and disability. Some children, 
however, continue to have moderate to severe levels of disability and predictors of these 
were higher levels of CHAQ at baseline, higher PGE scores and female gender.  
Although this study has different aims to what the current proposed study does, it is a 
large, well constructed study that looks at variables and characteristics that describe the 
functional disability and disease characteristics in this group. Strict and meticulous use of 
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 The main issue however is that the current study will be a prospective cross sectional 
study that enrols patients once at a random clinic visit. Therefore, the data will not be 
longitudinal, with some patients being first presentations and some being many years into 
treatment. For these reasons, in the table below, data from the 1 year follow up cohort 
has been summarised. This is however a limitation to how much the two data subsets can 
be compared. 
3.4.3 Turkey 10 
In 2008, a descriptive study was published from Turkey. The aim was very similar to the 
current study in that clinical and laboratory features of JIA in Turkish children were 
evaluated. A total of 196 patients were included in a retrospective record review. ILAR 
subtype, age, gender, ANA, HLA B27 and Rheumatoid factor (RF) results were collected. 
This study was descriptive and did not look at functional disability, general wellbeing or 
pain evaluation.  It was found that there is a very different profile to JIA in western 
countries. There were higher rates of polyarticular JIA, higher rates of male JIA and lower 
rates of ANA positivity. 
This clinical data is very useful for comparing the Western Cape population as it is data 
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3.4.4 Paediatric Rheumatology International Trials Organisation (PRINTO) 
multinational trial 11 
Any literature review would not be complete without including the large PRINTO series. 
This is a collaborative multicentre study that enrolled 3167 patients with JIA, and 3123 
healthy patients from 30 countries.  Countries were divided up into regions as illustrated 
below. 
Western Europe-Austria, Belgium, Denmark, Finland, France, Germany, Italy, 
Greece, the Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, UK and 
Israel 
Eastern Europe-Bulgaria, Croatia, Czech Republic, Georgia, Hungary, Latvia, 
Poland, Russia, Slovakia and Serbia-Montenegro 
Latin America-Argentina, Brazil, Chile and Mexico 
The aim was to compare health related quality of life and to identify clinical determinants 
for poor health related quality of life in patients with JIA from the above geographical 
areas. CHAQs were translated into multiple languages, and used to assess functional 
disability. Active joint count, limited joint count, PGE, VAS and ESR were evaluated in each 
patient. Children were classified according to the ILAR classification. Interestingly, in the 
results, there is no differentiation between polyarticular RF positive and polyarticular RF 
negative patients.  Enthesitis related arthritis as well as psoriatic arthritis patients were 
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The results of the study indicate that patients with JIA have a significant impairment of 
their health related quality of life compared to healthy peers. Disability and pain are the 
most important determinants of physical and psychosocial wellbeing irrespective of 
geographic area of origin. It was found that children from Eastern Europe and Latin 
America experienced a more severe disease, had a lower frequency of systemic disease, 
less female predominance and generally presented later than children from Western 
Europe. 
This is therefore a very useful study as it provides a lot of data describing the disease in 
developed and developing areas.  It also confirms that the measurements used are useful 
for extrapolating the quality of life of patients, irrespective of area of origin.  
In table 1. below, results have been summarised based on the 3 geographical areas 
mentioned above. Means are used in this data to describe categorical variables, but no 
specification of whether data is normally distributed or not is given. 
3.4.5 India 12 
A  longitudional cohort study was recently published from India which classifies and 
describes a cohort of Indian patients very well. The aim of the study was to describe a 
cohort of patients, as well as compare the ILAR classification system with the ACR2 and 
European Spondyloarthropathy Study Group classification systems13. 
 235 patients were reviewed over 11 years, and classified, very thoroughly into ILAR 
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longitudinal cohort. Clinical details, and investigation profiles for the first year of disease 
were recorded. 
It was found that enthesitis related arthritis(ERA) was the most common subtype. The 
frequency of RF positivity was unexpectedly high. The incidence of ANA positivity was 
strikingly low, although they did use the ELISA testing method which has been  shown  to 
detect fewer ANA in children with JIA than Hep 2 immunofluorescence17. A high level of 
RF positivity was found in children classified as undifferentiated arthritis. It was also 
found that 16% of children that did not classify as ERA (either female or age less than 6 
years old) in the polyarticular and oligoarticular subtype tested positive for HLAB27.  They 
therefore questioned the value of HLA B27 and RF testing in India to determine ILAR 
classification. 
The authors noted limitations to the study that are related to challenges similar to the 
South African context. It was difficult to accurately determine onset of disease, due to 
poor patient recall and insufficiency of early records. Several of the children lived in 
poorly resourced, rural communities and they had to exclude some patients as they only 
had had one RF study. As they mention, a Nordic study done recently shows that less than 
50% of cases of polyarthritis and less than 35% of cases with oligoarthritis could actually 
achieve 2 RF tests as specified by the ILAR classification system18. 
This study does not describe the disease characteristics or functional outcome but does 
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different profile to other countries, with very high rates of ERA. It also highlights some of 
the difficulties of the ILAR classification in a developing, under resourced setting. 
The methods of the various studies are summarised in the table 1. below 
Table 1 
Study  Setting Method No. Patients Time period 
Morocco8 Tertiary Cross sectional 
prospective 
80 18 months 
UK9 Tertiary Longitudional 
inception cohort 
740 1 year 
Turkey10 Tertiary Retrospective 
record review 
196  




India12 Tertiary Longitudional 
cohort 
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Table 2 Results of various studies: values are expressed as medians unless * indicates a 
mean value 
 







N 80 740 196 2102 668 397 235 
Age current 10.85* 7.6 8.8* 9.4* 6.8* 10.7*  
Age at onset 7.53* 6.6 6.8* 5.4* 11.4* 6.6* 12 
Female 47 59% 476 64% 94 47% 1484 83% 428 72% 255 68.3% 98 41.7% 
Systemic 21 26% 42 6% 30 15.3% 345 16.4% 155 23% 113 28.5% 19 8% 
Poly RF+ 25 31.5% 23 3% 13 6.6% 686 32% 222 33% 161 40.6% 28 12% 
Poly RF- NA NA 148 20% 60 30.6% NA NA NA NA NA NA 41 17% 
Oligo Persistent 30 37,5% 353 48% 48 24.4% 620 29.5% 211 31.6% 87 21.9% 39 17% 
Oligo extended 4 5% 32 4% 19 9.6% 451 21.5% 80 12% 36 9% 10 4% 
ERA   51 7% 19 10.3%       84 36% 
Psoriatic   61 8% 2 1%       3 1% 
Undifferentiated   30 4% 5 2.5%       11 5% 
VAS pain(mm) 28.4* 9  28* 23* 27*  
VAS 
general(mm) 
 6  25* 28* 24*  
Limited joints 1.78* 0  5.9* 8.6* 10.1*  
Active joints 4.39* 0  5.3* 6.7* 7.1*  
CHAQ 0.84* 0.25  0.7* 0.6* 0.8*  
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3.4.6 The South African Context 
As far as could be found in this data search, there has only been one study done that 
describes disease characteristics of  juvenile arthritis in South Africa. It is a study done in 
Durban in 1984. The aim was to evaluate Indian and Black children with juvenile chronic 
arthritis14. It was a retrospective review of Black and Indian children between the ages of 
1-16 who fulfilled EULAR criteria1 for the diagnosis of juvenile chronic arthritis.  60 
patients were studied, of whom 42 were Black and 18 of Indian descent.   
The results showed similar data to the Indian and Turkish populations described above. A 
predominance of polyarticular arthritis and a relatively low occurrence of  pauciarticular 
arthritis was found. It was noted that there was a high occurrence of rheumatoid factor 
positivity, a low level of ANA positivity and an equal female to male ratio. The results are 
summarised below, in table 2. 
Notable, any enthesitis related or spondyloarthropathy type arthritis as well as psoriatic 
type was not included.  
This is a relatively small study which currently has limitations on its’ usefulness due to use 
of the old classification criteria, but it was the only  study found, that attempts to describe 




















Mode of Onset no % Black Indian Presence of 
rheumatoid factor 
Systemic 9 15 6 14% 3 16% 4 44% 
Polyarticular 29 48.3 21 50% 8 44% 13 44.8% 
Pauciarticular 22 36.7 15 35.7 7 39% 5 22.7% 
 
 3.5 Limitations to literature review  
All of the above mentioned studies have been done in a tertiary hospital setting. This may skew 
results in  2 ways. Patients who attend a paediatric rheumatology clinic may have more severe 
disease than those in the community with milder disease. These milder forms have a higher 
likelihood of going into remission and may never make it to tertiary centres. Firstly, this may cause 
a skewed perception that JIA in an area is more severe than it may actually be.In addition, the 
subtypes causing the most severe disease will be most likely to attend a specialised clinic and 
therefore, skew the relative proprtions of disease subtypes for that area. 
The literature review also highlights that the studies have different methodologies and therefore 
make meaningful comparison difficult.  
  
3.6 Conclusion 
The main objective of this literature review was to 
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To assist in finding validated variables and scores that have been standardly used 
to assess the type, functional outcome and severity of JIA.  
The above literature should show that these objectives have been met. A number of 
recent and relevant studies have been quoted. They are from a wide range of different 
geographical areas and population subtypes. These show that JIA is a well described 
disease with a lot of recent work having been done to standardise and globalise the 
classification.  JIA is also a disease that has a different clinical picture in differing regions 
and population groups. It highlights that there is very little work done in describing JIA in 
African population groups, specifically the South African population. This literature review 
has been helpful in determining standard variables that are used to assess JIA. CHAQ is a 
universally used as a tool for assessing functional disability in the above studies. Clinical 
determinants that are often used are VAS, PGE and joint counts. ESR is useful in 
determining severity of JIA.  
The literature review is therefore useful in finding tools to achieve the aim of the current 
study, which is  to describe clinical characteristics and functional disability in the Western 
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4 Journal article  
4.1 Abstract 
  Background. JIA is a disease that shows wide variations between differing 
populations. Due to recent international consensus on classification criteria, JIA 
has been widely described in many countries and population groups. There has 
been almost no data that describes JIA in an African, specifically Sub-Saharan 
African setting. 
Objective. To describe disease characteristics and functional disability in two 
tertiary centres in the Western Cape, South Africa 
Methods.86 children were recruited during random clinic visits to rheumatology 
clinics at Tygerberg and Groote Schuur Hospital between April 2010 and April 
2011. Children were diagnosed using International League of Associations for 
Rheumatology (ILAR) 2001 classification criteria. Consent was obtained, medical 
records examined, Childhood Health Assessment Questionnaires (CHAQ), visual 
analogue scales (VAS) for pain and general wellbeing were completed and all 
children were examined by a researcher in conjunction with a paediatric 
rheumatologist. HIV status as well as tuberculosis disease and treatment were 
investigated.  
Results. A total of 86 children were enrolled. 8 children were excluded (2 HIV 
arthropathy, 1 TB arthritis, 1 SLE, 4 insufficient data) leaving a total of 78 
patients. There was an equal female to male ratio-39 males and 39 females. 
There were 6 systemic JIA (7.69%), 17 oligoarthritis (21,79%), 11 polyarthritis 
rheumatoid factor (RF) positive  (14.10%), 21 polyarthritis RF negative (26.9%), 1 
psoriatic arthritis (1.28%), 18 enthesitis related arthritis (23%) and 4 
oligoextended JIA (5.12%). The median CHAQ for the group was 0.5, the median 
VAS for pain was 18mm and median VAS for general wellbeing was 25mm. 
Kruskal-Wallis equality-of-populations rank test showed significant differences 
(p<0.05) between CRP, ESR, number of active joints and limited joints between 
subtypes. 
Conclusion. JIA in the Western Cape of South Africa has a very different profile 
to JIA that has been described elsewhere. Disease subtypes, specifically 
enthesitis related arthritis and polyarthritis are more prevalent. There are 
unique challenges in this setting, with differing disease course, later 



















Juvenile idiopathic arthritis (JIA) is a poorly described disease in South African children. 
According to International league of Associations for Rheumatology (ILAR)1, it is defined 
as arthritis that begins before the 16th birthday and persists for at least 6 weeks, other 
conditions being excluded. In 2001 at Edmonton, the ILAR proposed a standardised 
definition and classification of JIA. This classification has, in recent years, been used  all 
over the world to describe disease characteristics in various populations and nationalities. 
Included in these recent studies are large multicentre trials2;3 and smaller studies from 
both developed and developing countries4;5;6. 
South Africa is a country that is poorly resourced in the field of Paediatric Rheumatology. 
There are few centres with recognised paediatric rheumatologists in South Africa.  There 
has only recently been training positions for paediatric rheumatologists and funding for 
these positions remains a problem. Children with paediatric rheumatological diseases, 
specifically JIA, have therefore been treated by general paediatricians, general 
practitioners, adult rheumatologists, or gone untreated.  In South Africa, there is also a 
high burden of infectious diseases (HIV, TB) as well as social diseases (poverty, 
malnutrition). These diseases demand a great amount of attention and resources, and 
therefore the amount of research  into rheumatological diseases such as JIA has been 
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JIA is a disease with severe implications for patients and families. Function and quality of 
life can be severely affected7. JIA is an important cause of short and long term disability19 
and is the most common rheumatological disease in children8. 
Studies in developed countries have estimated a prevalence of JIA that varies between 
0.0720-421 per 1000 children8.There is very little consensus on the exact prevalence of JIA. 
As evidence  increasingly shows, it is clear that JIA prevalence is underestimated. The best 
studies to approximate prevalence are those that involve large numbers of children in 
homes or schools with a history and examination done by an experienced 
rheumatologist8.  Clinical case studies produce relatively lower prevalence due to non-
diagnosed or misdiagnosed cases in the community8. In the South African setting, there is 
relatively poor access to healthcare, complex economic migration and large 
socioeconomic discrepancies. Therefore these studies are extremely difficult and no 
accurate prevalence figures are available for South Africa. 
JIA is a disease that shows variation in expression between different ethnicities9.There is 
substantial interest in the differences in JIA in various parts of the world and various 
population groups.2;3;5  
Many studies have been done recently to describe JIA as per the new, standardised ILAR 
classification. The Paediatric Rheumatology International Trials Organisation(PRINTO)  
recently performed a study of 3167 patients from 3 large geographical areas (Western 
Europe, Eastern Europe and Latin America)2 . Over the last 10 years, studies have been 
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disease including health related quality of life, classification, disease activity, functional 
disability, clinical and laboratory features. A drawback is that many of these studies are 
based at tertiary centres, and may not have similiar methodology or objectives. This 
makes true epidemiological inferences of JIA difficult. These studies do serve to highlight 
what may be geographical differences in JIA presentation. 
The only South African literature to describe disease characteristics of JIA, that could be 
found, was a study done in the Kwazulu Natal region of South Africa in 198411.Black and 
Indian children were specifically included only and patients were classified according to  
the 1977 European League Against  Rheumatism criteria22 for juvenile chronic arthritis. 
This classification divided JIA into polyarticular, pauciarticlar and systemic subtypes only. 
A predominance of polyarticular JIA and and equal male to female ratio among patients 
with juvenile chronic arthritis was described.  This study was the only study to describe JIA 
in South Africa in the last 30 years. Unfortunately it’s usefulness now, is limited by the use 
of the old European classification.   
Cape Town is an area with a unique population profile in terms of ethnicity and race. The 
population of children (0-17years old) in Cape Town is 1.7 million 17. Of these children 
approximately 34.9% are black african, 44% are coloured, 1.8% are asian and 19.3% are 
white15. 
Cape Town is a diverse city with 2 tertiary hospital centres. The first is Groote Schuur 
Hospital which is the academic hospital associated with the University of Cape Town, and 
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these hospitals service the Western Cape of South Africa as tertiary referral centres and 
both have a paediatric rheumatology clinic and collaborate with each other. 
The aim of this study, therefore is to describe the disease characteristics and functional 
disability in a sample of children from 2 tertiary centres in Cape Town, South Africa.  
4.3 Methods 
4.3.1 Setting  
Patients were recruited from the Groote Schuur and Tygerberg Hospital Paediatric 
Rheumatology clinics between March 2010 to April 2011. 
4.3.2 Participants 
Participants were patients attending the above clinics who were diagnosed with Juvenile 
Idiopathic Arthritis as per ILAR 2001 definition. Patients were recruited at random visits 
when a researcher was available. No limitation was set on whether it was the patients’ 
initial or ongoing visit. 
4.4 Procedures  
4.4.1 Data Sheet  
A researcher collected patient data on a data collection sheet (appendix 6).  This data 
included  
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-Type of arthritis   
 
-Blood results- C-reactive protein(CRP), erythrocyte sedimentation rate (ESR), -
haemoglobin (HB), platelets (plt), antinuclear antibodies (ANA), rheumatoid factor 
IgG (RF), human leukocyte antibody B27 (HLA B27), alanine transaminase (ALT), 
aspartate  transaminase (AST). Blood was not taken for the purpose of the study, 
only as part of ongoing patient care. It must be noted that the majority of ANA 
blood tests were done were ELISA tests as HEp 2 immunofluoescent ANA studies 
are only available at Tygerberg Hospital.  
-Previous HIV test results and whether or not the child is on antiretroviral drugs. 
-Previous diagnosis or current diagnosis of tuberculosis as well as current or 
previous treatment 
4.4.2 Childhood Health Assessment Questionnaire 
(Appendix 2, 3, 4, 5) 
A childhood health assessment questionnaire (CHAQ) was filled out by the parent, 
or when capable, the child. The CHAQ measures the child’s ability to perform 
functions in 8 areas (dressing and grooming, getting up, eating, walking, hygiene, 
reach, grip and activity). Each question is scored from 0 to 3 (0 = no difficulty, 1 = 
some difficulty, 2 = much difficulty, 3 = unable to do so). The question with the 
highest score determines the score for that functional area. If aids or devices are 
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recorded for the corresponding functional area. The scores for each of the eight 
functional areas are averaged to calculate the CHAQ disability index (DI), which 
ranges from 0 to 3 (0 = best; 3 = worst). The parent's version of the CHAQ 
incorporates a doubly-anchored horizontal 100mm visual analogue scale (VAS) for 
the assessment of the child's overall well-being (with anchors of ‘0 = very well’ and 
‘100 = very poor’) and a doubly-anchored horizontal 100mm VAS for the 
assessment of the intensity of the child's pain (with anchors of ‘0 = no pain’ and 
‘100 = very severe pain’)2. 
 
The CHAQ is a well validated international tool and has been used in many recent 
trials12 . The CHAQ was translated into Zulu, Xhosa and Afrikaans for the purposes 
of this study. Unfortunately these translations have not been formally validated. 
 
4.4.3 Joint Count 
(Appendix 7) 
All participants were then examined by a researcher in conjunction with a 
paediatric rheumatologist and a joint count was done and recorded on 2 joint 
diagrams- one for limited joints (limited range of movement) and one for active 




















Data was collected into a Microsoft excel spreadsheet using a number assigned to each 
patient. Categorical variables were assigned numerical codes. The data was then analysed 
using STATA software and a number of statistical tests were applied. A Shapiro Wilks test 
was done on each  numerical variable for the whole sample, and for each variable per 
type. If p value was >0.05 data was presumed to be normally distributed. Median and 
mean values were obtained. Categorical values are expressed in absolute frequency and 
percentage. Kruskal-Wallis equality-of-populations rank tests were performed to assess if 
there were significant differences in  numerical variables per subtype of JIA. 
4.6 Ethics 
Ethics approval was granted by the University of Cape Town and Stellenbosch University 
ethics committees respectively. All parents and, where possible, capable children (age 
over 16) were given consent forms prior to enrolling in the study and had all procedures 
explained to them. It was clearly explained that should the patients not wish to 
participate in the study, it would not affect their ongoing care. No additional blood 
tests/procedures or radiological tests were done for the purposes of the study. 
Confidentiality was ensured for all participants.  
No conflict of interest was declared. This study was done by Kate Weakley for the 
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minimal and covered personally by the researcher. Patients were not paid for their 
participation or offered any incentive. 
4.7 Results 
A total of 86 children were enrolled in the study.   
4 patients were excluded due to insufficient clinical data collection. Of these, 1 patient 
with oligoarthritis had an insufficient clinical examination recorded; 1 patient with 
oligoarthritis  had an incomplete consent form and 2 patients (1 polyarthritis, 1 
oligoarthritis)  had  blood results that could not be traced. 2 Children were diagnosed with 
HIV related arthritis and excluded. 1 child initially had arthritis and then developed SLE, so 
was excluded and 1 was later diagnosed with tuberculosis(TB) arthritis so was excluded. 
Therefore 8 children were excluded leaving a total of 78 patients. 
There was an exactly equal female to male ratio-39 males and 39 females. Mean age at 
diagnosis was 7.31 years of age (95% CI 0.93). Mean current age was 12.40 years old (95% 
CI 1.28).  Out of these, there were 6 systemic JIA  patients (7.69%), 17 oligoarthritis 
patients(21,79%), 11 polyarthritis rheumatoid factor (RF) positive  (14.10%), 21 
polyarthritis RF negative (26.9%), 1 psoriatic arthritis (1.28%), 18 enthesitis related 




















 Systemic Oligo PolyRF+ PolyRF- Psoriatic ERA Oligoextended 
no 6 17 11 21 1 18 4 
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Table 2-Variables per type. All values are expressed as medians as they show non normal 
distribution overall. If  the variable was normally distributed within a subtype, the mean is 
given in brackets. 









Systemic 0.437(0.875) 10.5(14.8) 12(23.3) 3(5.66) 0 58.5(65.5) 
Persistent 
oligo 
0.375 19 23 1 1(1.17) 9 
Oligo 
Extended 
0.563(0.59) 21(28.2) 34.5(35.7) 5.5(5.5) 4.5(4) 5(6) 
Poly RF+ 1(1.05) 20(32.2) 30(30.8) 3 9 42(40.9) 
Poly RF- 0.875(1.12) 21(27.8) 27(31.2) 2 6 12.5 
ERA 0.125 14 14 1 1 12 
Total 0.5 18 25 2 2 14 
 
Each subtype had a mean CHAQ, pain VAS, General VAS, active joint count, limited joint 
count, ESR and CRP, as can be seen in table 2 . Shapiro Wilks testing for normality was 
done on all variables for the total cohort as well as per type. For the total cohort, all of the 
variables had p values <0.05 and were therefore not normally distributed. Therefore, in 
table 2, the values are given as medians, even though within some subgroups values may 
have been normally distributed. The values in brackets are mean values where that 
variable was normally distributed within that type as evidenced by a Shapiro Wilki test 
with a p value >0.05. As there was only 1 psoriatic arthritis patient, it has been excluded 
from this table. 
The Kruskal-Wallis equality-of-populations rank test showed significant differences 
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Joints p=0.0003, Active Joints p=0.0013, CRP p=0.0061, ESR p=0.003. See figures 2,3 and 4 
below. 
ESR vs. Type 
ESR showed significant differences within type p=0.003 
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Active Joints vs Type 
Active joints showed significant differences within type p=0.0013 
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Limited Joints vs. Type 




3 patients were ANA positive (1 oligoarthritis, 2 oligoextended).Of these 2 were 
immunofluorescent HEp 2 ANA assays and 1 was an ELISA. 18 were HLA B27 positive, all 


















JIA has a very different profile in the Western Cape of South Africa compared to other 
places where it has been described.  
Table 3 summarises some of the differences between various populations in some recent 
studies that use the ILAR classification from developed and developing countries. The 
categorical variables are expressed as absolute frequencies and percentages. The 
numerical variables are all expressed as medians unless specified by *. Even though our 
data is not normally distributed the mean values are included in brackets for comparison 
purposes to the othe study cohorts. It must be noted that the studies were all done 
recruiting patients at random clinic visits, similiar to our data, except for the UK Childhood 
Arthritis Prospective Study (CAPS)3, which recorded data from presentation and one year 
follow up.The one year data is included in the table below, but it is important to note as 
the outcome data (CHAQ, joints, VAS pain and general) are very different from the other 
cohorts. 
All of the studies mentioned have been done in a tertiary hospital setting. This may skew results in  
2 ways. Patients who attend a paediatric rheumatology clinic may have more severe disease than 
those in the community with milder disease. These milder forms have a higher likelihood of going 
into remission and may never make it to tertiary centres. Firstly, this may cause a skewed 
perception that JIA in an area is more severe than it may actually be.In addition, the subtypes 
causing the most severe disease will be most likely to attend a specialised clinic and therefore, 
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differing methodology and this must therefore be noted as a potential limitation to the 
comparison below. The methodology of each study is summarised in table  4. 
Table 3. Median values represented unless * marks mean value. 













N 80 740 196 2102 668 397 235 78 
Age current 10.85*  8.8* 9.4* 6.8* 10.7*  12.4* 
Age at onset 7.53* 7.6 7.0* 5.4* 11.4* 6.6* 12 7.3* 
Female 59% 64% 47% 83% 72% 68% 41.7% 50% 
Systemic 26% 6% 15.3% 16.4% 23% 28.5% 8% 7.69% 
Polyarthritis 31.5% 23% 37.2% 32% 33% 40.6% 29% 40.9% 
Poly RF+  3% 6.6%    12% 14% 
Poly RF-  20% 30.6%    17% 26.9% 
Oligo Persistent 37,5% 48% 24.4% 29.5% 31.6% 21.9% 17% 21.8% 
Oligo extended 5% 4% 9.6% 21.5% 12% 9% 4% 5% 
ERA  7% 10.3%    36% 23% 
Psoriatic  8% 1%    1% 1.28% 
Undifferentiated  4% 2.5%    5%  
VAS pain(mm) 28.4* 9  28* 23* 27*  18(24.9*) 
VAS general(mm)  6  25* 28* 24*  25(28.4*) 
Limited joints 1.78* 0  5.9* 8.6* 10.1*  2(6.51*) 
Active joints 4.39* 0  5.3* 6.7* 7.1*  2(3.85*) 
CHAQ 0.84* 0.25 
 
 0.7* 0.6* 0.8*  0.5(0.73*) 





















Study  Setting Method No. Patients Time period 
Morocco4 Tertiary Cross sectional 
prospective 
80 18 months 
UK3 Tertiary Longitudional 
inception cohort 
740 1 year 
Turkey6 Tertiary Retrospective 
record review 
196  




India5 Tertiary Longitudional 
cohort 
235 11 years 
South Africa Tertiary Prospective cross 
sectional 
78 1 year 
 
Age. Out of the above studies, the present data has the oldest mean current age(12.4 
years) and the 2nd youngest mean age of onset (7.3 years). One of the reasons for this 
could be that the present studies’ patients are being referred to treatment centres 
relatively long after their initial onset of symptoms.This cannot be confirmed as we did 
not capture the age of diagnosis versus the age of onset of symptoms, rather reported 
age at onset and current age at the time of the study. These are the same variables  as the 
above studies, but we still have the oldest mean current age.  In our socioeconomic 
scenario, we postulate that one of the most likely reasons for this is a delay in diagnosis, 
leading to a delay in inducing disease remission and therefore an older group of children 
who actively attend our clinics. The Western Cape is a large area that has many rural 
areas with difficult access. There is also a lack of awareness of JIA, delaying the time to 
diagnosis. JIA is often misdiagnosed as tuberculosis(TB). Often JIA is only considered after 
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to rule out TB. Although we collected the total number of patients who actually had TB, 
we did not collect the number who had been incorrectly diagnosed as TB and therefore 
had a diagnosis of JIA  delayed. This would make an interesting study in the future. We 
theorise, therefore, that there is a longer disease course before presentation to a 
paediatric rheumatology centre.   
Sex.Next to India5(58.3%) and Turkey6(53%), the present data has the 3rd highest rate of 
male JIA(50%), with all of the other regions having a female predominance as is classically 
described in western populations.There is a difference in sexual distribution per subtype.  
If ERA is excluded them from the our group, there is a 65% female predominance. 
Polyarthritis.This data shows the highest rate of rheumatoid factor positive 
polyarthritis(14%) in the studies compared above, and the second highest rate of 
rheumatoid factor negative polyarthritis(26.9%) next to Turkey6(30.6%). This is significant 
and in keeping with previous data that describes African population groups as having a 
higher risk of polyarthritic JIA 9;11;13. A limitation that must be mentioned in the present 
study is that the ILAR criteria require at least 2 RF assays to be done at least 3 months 
apart in the first 6 months of the disease1. Due to constraints on resources, this is not 
standard practise in our clinics, and one positive or negative assay was considered 
sufficient to classify a patient with polyarthritis. This has been a difficulty with the ILAR 
classification, especially in poorly resourced settings, with it being mentioned in the 
Indian study5 and in a previous study of Nordic children14. In the Nordic group 55% of 
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RF had not been done twice14. It is postulated that this would probably cause RF positive 
patients to be underrepresented in our polyarticular subtype, as only one RF is being 
done, and that it may be more prevalent than is reported. 
 Oligoarthritis.Lower rates of oligoarthritis(21.8% oligopersistent, 5% oligoextended) are 
seen in the present cohort than described in Western populations. This is in keeping with 
previously described data that shows that non European populations have a decreased 
relative risk of suffering from oligoarthritis9 . There is also a very low rate of ANA positivity 
described. A limitation that must be mentioned is that there are technical issues with the 
available laboratories, with only a small proportion of patients having had HEp2 
immunofluorescent ANA studies done and the majority being ELISA studies. It has been 
shown that ELISA ANA testing shows fewer ANA than HEp 2 immunofluorescense 
testing23;24. 
 Enthesitis related arthritis. The present data describes the second highest rate of 
ERA(23%), second only to the Indian5 cohort(36%). It is much higher than the ERA rates in 
the data from the UK3 (7%) and Turkey6 (10.3%). The large PRINTO series states that there 
were too few ERA patients, so they were excluded from further consideration2.This is an 
interesting finding as ERA has not been previously associated with an African population. 
It has been described as being more prevalent in Asian populations and Indian 
populations9;5.  
A postulated reason for this is the unique population mix that is prevalent in the Western 
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South Africa, with a higher prevalence of coloured people (44%) compared to black
(34.9%)15 .This is not representative of the rest of the country where the majority of the 
population is black. The coloured population has mixed ancestry with some Asian and
European heritage which may account for the high levels of ERA . It may also be due to a
founder effect from the initial small population groups in the Cape. Psoriatic.There was 
also only 1 patient with psoriatic arthritis, which may be due to it being a rarer subgroup
in our setting but often, a family history of psoriasis was difficult to elicit in our patients.
Functional disability and outcomes. The markers of functional disability(CHAQ), visual 
analogue scales for pain and general wellbeing, as well as biomarkers of disease (ESR) are
compared to the other groups in the table below. Values are expressed as medians
unless* marks mean. Even though our variables are not normally distributed, means are 
given in brackets for comparison purposes.
Table 5. Values expressed as medians unless * marks mean













28.4* 9 25* 28* 24* 18(24.9*) 
VAS 
general(mm) 
6 28* 23* 27* 25(28.4*) 
CHAQ 0.84* 0.25 0.7* 0.6* 0.8* 0.5(0.73*) 
ESR 28* 9 30.7* 27.7* 31.2* 14 (25.1*) 
This shows that our cohort has a comparable mean  ESR, CHAQ, pain and general 
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UK  data is from a 1 year follow up and is therefore difficult for comparison purposes, but 
is a good example of excellent outcomes in a well resourced setting. A similiar 
longitudional study would be ideal in our patients to assess whether we are achieving 
comparable control of our patients’ disease. 
4.8 Conclusion 
JIA in the Western Cape of South Africa has a very different profile to JIA that has been
described elsewhere. There is an equal male to female predominance.Both RF positive 
and negative polyarthritis are more common than has been described elsewhere.There is
a high a relatively high rate of joint limitation, functional disability, pain and poor general 
wellbeing in these polyarthritis patients. There is a higher rate of ERA than has been
previously described in Africa. Lower rates of oligoarthritis are described. Disease
presentation is often later than elsewhere due to socioeconomic factors, confounding
diseases such as TB and lack of awareness and resources in paediatric rheumatology. 
There are difficulties with the ILAR classification in our setting, specifically regarding the
requirement of 2 rheumatoid factor tests. 
Therefore juvenile idiopathic arthritis has a unique disease profile and has unique 
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5.3 CHAQ Xhosa 
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5.4 CHAQ Zulu 
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5.5 CHAQ Afrikaans 
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5.6 Data collection sheet 





Sex Male:    Female: 




Mother/  Father/  grandparent/ other 
Level of 
schooling 
Gr1 / 2/ 3/ 4/ 5/ 6/ 7/ 8/ 9/ 10/ 11/ 12/ tertiary 
Area of 
residence 
ANA Positive / Negative   Titre: 
   RF Positive / Negative   Titre: 
HLA B27 Positive/ Negative    Titre: 






HIV Pos:    Neg:    CD4:   ARV: 
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5.7 Joint Count 













Juvenile Idiopathic Arthritis in two Tertiary Centres in the Western Cape, South Africa 
65 
5.8 Consent Form: Participation in study on arthritis in the Western Cape. 
Dear Parents: 
We are conducting a study on behalf of the University of Cape Town, to find out more 
details about children suffering from arthritis in the Western Cape. We will be looking at 
50-100 children with arthritis.
To participate in this study you will have to give consent for your child’s medical 
information to be evaluated by a doctor who will be attending the clinic to do the research. 
The doctor will ask you to answer some basic questions to find out details about how your 
child was found to have arthritis and how it has been treated. We will also ask you to fill in 
a form, which will give us an indication of how the illness affects your child. Depending
on the outcome of the questions we may also want to do an examination of your child’s 
joints. You will only need to be involved in the study once off for about 15 minutes. Your 
child’s medical information is totally confidential and will only be used for the purpose of
this study and will not be shared with anyone who is not directly involved in the research. 
The ethics committee members or auditors may inspect some of the documentation. We
will not take any blood tests or x-rays other than what is necessary to provide routine care
for your child. If your child is HIV positive this fact will be included in the study, but his 
or her identity will remain confidential.  His or her name will not be used in the study. 
Please note that there will be no monetary compensation for your participation or cost to 
yourself.
Your child will receive the same optimal care, whether you decide to participate in the
study, or not. You may withdraw from the study at any time. This will not affect your 
current treatment.
Benefits of the study are that there will be additional information on arthritis available to 
the western capes’ specific population, which may in the future be used to motivate for
more extensive treatment to become available. The study may be presented to international 
congresses, which would highlight the plight of your child and others.
Please feel free to ask us any questions if anything is unclear to you, before signing
permission for your child to join the study. Contacts-Principal Investigator- Dr K Weakley
0832977799 drkweakley@gmail.com. UCT ethics committee 021 4066626 
shuretta.thomas@uct.ac.za. Stellenbosch ethics committee-0219389207. This research has 
been approved by both UCT and Stellenbosch ethics committees. 
This study is in accordance with the International Declaration of Helsinki and other
applicable ethical codes.Thank you,
Dr Chris Scott
I, ______________________________________________, hereby consent to participate 
in this 
Study project, and for the medical information of my child 
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